BioSpace News Archive

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the fourth quarter and full year ended December 31, 2020 on Thursday, February 25, 2021 and host an investment community conference call at 9:00 a.m. EST / 2:00 p.m. GMT to discuss these financial results and provide a corporate update.

South Korea’s leading molecular diagnostics firm Seegene Inc. reported preliminary financial results for the fourth quarter and the fiscal year of 2020, showing records never seen before.

Proceeds enable advancement of our exosome therapeutics into the clinic and expansion of our world-leading exosome platform

Senior Executives Appointed to Lead Commercialization of Sense’s Products to Deliver Patient-Focused, Decentralized Healthcare

Year-end Report 2020 and an operational update will be presented by CEO Marty J Duvall and members of Oncopeptides Leadership team, Thursday February 18, 2021 at 14:00 (CET).

Metastatic biomarker Cyr61 found by researchers in 40% of breast cancer CTCs may be a novel therapeutic target in treating drug-resistant breast cancers

Approval for phase 1 dose-escalation and expansion study of pre|CISION FAP-activated doxorubicin pro-drug

Neuralgia is an abnormal symptom with effects like sharp, burning, and mostly severe pain, due to an irritated or damaged nerve.

The role of current-generation surgical robots is to assist operating surgeons rather than to replace them. By combining advantages of the operator and the robot, surgeons can achieve the desired outcome with high precision and accuracy.

Avivagen Inc is pleased to announce that a paper “Evaluation of fully oxidized β-carotene as a feed ingredient to reduce bacterial infection and somatic cell counts in cows with subclinical mastitis” reporting an independent trial conducted in New Zealand by Dr. Scott McDougall has been accepted for publication in the New Zealand Veterinary Journal.